Cas:20434-05-3 Bis(4-methoxyphenyl)phosphinic acid manufacturer & supplier

Chemical Name:Bis(4-methoxyphenyl)phosphinic acid

CAS.NO:20434-05-3

Synonyms:di(p-methoxyphenyl)phosphinic acid;Bis-(4-methoxy-phenyl)-phosphinsaeure;MFCD00010226;bis-p-methoxyphenylphosphinic acid;di-p-anisylphosphinic acid;bis(p-methoxyphenyl)phosphonic acid;bis-(4-methoxy-phenyl)-phosphinic acid

Molecular Formula:C₁₄H₁₅O₄P

Molecular Weight:278.24000

HS Code:2918990090

Physical and Chemical Properties:

Melting point:185-187ºC(lit.)

Boiling point:504.1ºC at 760 mmHg

Density:1.27g/cm3

Index of Refraction:1.578

PSA:65.57000

Exact Mass:278.07100

LogP:1.92500

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like di(p-methoxyphenyl)phosphinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bis-(4-methoxy-phenyl)-phosphinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00010226 Use and application,di-p-anisylphosphinic acid technical grade,usp/ep/jp grade.

Related News: At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good. Bis(4-methoxyphenyl)phosphinic acid manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. Bis(4-methoxyphenyl)phosphinic acid supplier The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. Bis(4-methoxyphenyl)phosphinic acid vendor The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. Bis(4-methoxyphenyl)phosphinic acid factory They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients.